(JIRE) J.P. Morgan Exchange-Traded - Ratings and Ratios
Developed Markets Equities, Diversification, MSCI EAFE Tracking
Dividends
| Dividend Yield | 2.33% |
| Yield on Cost 5y | 10.63% |
| Yield CAGR 5y | 16.23% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 12.7% |
| Value at Risk 5%th | 21.5% |
| Relative Tail Risk | 3.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.16 |
| Alpha | 14.31 |
| CAGR/Max DD | 1.28 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.430 |
| Beta | 0.644 |
| Beta Downside | 0.630 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.61% |
| Mean DD | 2.57% |
| Median DD | 1.64% |
Description: JIRE J.P. Morgan Exchange-Traded November 05, 2025
JIRE is a U.S.- domiciled exchange-traded fund that commits at least 80 % of its capital to equity securities of companies in developed markets, aiming to outperform the MSCI EAFE Index while preserving comparable sector and geographic risk characteristics. The manager primarily selects stocks that are constituents of the MSCI EAFE universe but retains discretion to hold non-index securities when they are judged to add incremental value.
As of the most recent filing (Q3 2024), JIRE reports an expense ratio of 0.30 % and total assets under management of roughly $1.2 billion. Its 12-month total return trails the MSCI EAFE by about 0.4 percentage points, reflecting modest underperformance despite a dividend yield near 2.1 %. Key drivers for the fund’s performance include the strength of U.S. dollar-denominated earnings in Europe and Japan, the outlook for global interest rates (which affect valuation multiples in the large-cap blend space), and sector weightings that tilt toward financials and consumer discretionary-both of which are sensitive to economic growth cycles in the Eurozone and Japan.
If you want to dig deeper into how JIRE’s risk-adjusted returns compare to peers, consider using ValueRay’s analytical tools to run scenario analyses and factor breakdowns.
What is the price of JIRE shares?
Over the past week, the price has changed by +0.73%, over one month by -0.18%, over three months by +4.05% and over the past year by +25.51%.
Is JIRE a buy, sell or hold?
What are the forecasts/targets for the JIRE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 89 | 17% |
JIRE Fundamental Data Overview December 03, 2025
Beta = 1.06
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 9.52b USD (9.52b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 9.52b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 9.52b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.39% (E(9.52b)/V(9.52b) * Re(8.39%) + (debt-free company))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for JIRE ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle